T2 Biosystems Inc (LTS:0A57)
$ 0.3401 0.0048 (1.37%) Market Cap: 7.26 Mil Enterprise Value: 24.12 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 29/100

Q2 2023 T2 Biosystems Inc Earnings Call Transcript

Aug 07, 2023 / 08:30PM GMT
Release Date Price: $25.6 (+0.83%)
Operator

Greetings. Welcome to T2 Biosystems, Inc. Second Quarter 2023 Earnings Conference Call. (Operator Instructions) Please note, this conference is being recorded.

I will now turn the conference over to your host, Trip Taylor, Investor Relations at T2 Biosystems. You may begin.

Philip Taylor
Gilmartin Group LLC - Associate

Thank you, operator. I'd like to remind everyone that comments made by management today and answers to questions will include forward-looking statements. Those include statements related to T2 Biosystems' future financial and operating results and plans for developing and marketing new products. Forward-looking statements are based on estimates and assumptions as of today and are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied by these statements, including the risks and uncertainties described in T2 Biosystems' annual report on Form 10-K filed with the SEC on March 31, 2023, and other filings the company makes with the SEC from time to time. The company undertakes no

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot